Published in
Oxford University Press (OUP), The Journal of Clinical Endocrinology & Metabolism, 11(100), p. 4146-4154
DOI: 10.1210/jc.2015-2616
Links
Tools
Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
Journal article published in 2015 by
Eleni Daniel,
Simon Aylwin,
Omar Mustafa,
Steve Ball,
Atif Munir,
Kristien Boelaert,
Vasileios Chortis 
,
Daniel J. Cuthbertson,
Christina Daousi,
Surya P. Rajeev,
Julian Davis,
Kelly Cheer,
William Drake,
Kirun Gunganah,
Ashley Grossman
and other authors.
,
Daniel J. Cuthbertson,
Christina Daousi,
Surya P. Rajeev,
Julian Davis,
Kelly Cheer,
William Drake,
Kirun Gunganah,
Ashley Grossman
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 
Abstract
Cushing's syndrome is a severe condition with excess mortality and significant morbidity necessitating control of hypercortisolemia. There are few data documenting use of the steroidogenesis inhibitor metyrapone for this purpose.